The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1.245 million delivery order contract to Starks Associates Inc. under the Preclinical Services for HIV Therapeutics indefinite-delivery/indefinite-quantity master contract. Starks Associates Inc. will conduct synthesis and acquire batches of compounds for subsequent biological in vitro and in vivo testing in support of preclinical services for HIV therapeutics research. The work will be performed...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1,181,588.00 delivery order contract to Starks Associates Inc. under the Preclinical Services for HIV Therapeutics master indefinite-delivery indefinite-quantity contract. Starks Associates Inc. will conduct synthesis and acquire batches of compounds for subsequent biological in vitro and in vivo testing in support of preclinical services for HIV...
Starks Associates Inc. was awarded a $5,908.72 delivery order against the Preclinical Services for HIV Therapeutics master indefinite-delivery/indefinite-quantity (IDIQ) contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The purpose of this task order is for Starks Associates to develop and deliver a quality assurance/quality control plan and participate in a task order initiation meeting to support preclinical services for HIV therapeutics....
This is a federal contract award to Starks Associates Inc., a for-profit subchapter S corporation, by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH). The contract, valued at $15,287,463.93, is for the resynthesis of therapeutic agents for the treatment of infectious diseases. The contract is a definitive contract with a cost-plus-fixed-fee pricing type and has a completion date of September 15, 2011. The contract is set...
This is a federal contract award to Starks Associates Inc., a for-profit subchapter S corporation, by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH). The contract is for the "Synthesis of Therapeutic Agents for Treatment of Infectious Diseases" and has a ceiling value of $8,129,171.83. The contract is a definitive contract of the cost-plus-fixed-fee type. Starks Associates Inc. is the prime contractor and has...
This task order, awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Southern Research Institute, funds the guaranteed minimum amount under the Preclinical Services for HIV Therapeutics contract vehicle. The purpose of this delivery order is to provide preclinical services in support of HIV therapeutics research and development efforts. With a potential value of $0.00 and cost-no-fee pricing, this task...
This task order funds the guaranteed minimum amount under the prime contract between Research Triangle Institute (RTI) International and the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The purpose is to support preclinical services for HIV therapeutics research under the larger Preclinical Services for HIV Therapeutics master IDIQ contract vehicle. With a potential value of $0.00, this delivery order was awarded on October 15, 2020 to RTI...
This task order funds the guaranteed minimum amount under the Preclinical Services for HIV Therapeutics contract vehicle with the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The $0 potential value indicates the order is funding pre-established contract capacity rather than discrete services. Alchem Laboratories Corporation will perform the preclinical services as the prime contractor, with place of performance in Alachua, Florida. No set-aside...
This task order funds the guaranteed minimum amount under the Preclinical Services for HIV Therapeutics contract vehicle held by Sri International. The National Institute of Allergy and Infectious Diseases, a component of the Department of Health and Human Services' National Institutes of Health, awarded this $0 delivery order against the multiple award indefinite delivery/indefinite quantity master contract. Sri International will perform preclinical services in West Menlo Park, California in...
This task order, awarded by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases, funds the guaranteed minimum amount under the Preclinical Services for HIV Therapeutics contract held by The University of Iowa. The purpose of this $0.00 delivery order is to provide preclinical services in support of developing therapeutics to treat HIV/AIDS. Set to be completed by May 2021, this award draws from the potential $0...